Key result
Systemic hypertension did not significantly affect subfoveal choroidal thickness compared to healthy controls (P≤0.611).
Why the study?
Does systemic hypertension affect subfoveal choroidal thickness in patients over 45 years of age?
Case-Control (n=232)
Does systemic hypertension affect subfoveal choroidal thickness in patients over 45 years of age?
p-value: p=≤0.611
Systemic hypertension, even in the presence of left ventricular hypertrophy and arterial stiffness, does not significantly affect subfoveal choroidal thickness.
No takes yet. Share an insight, caveat, or question.
SFCT assessment adds no clinical value in hypertension now; leaves open any longitudinal choroidal effects in broader populations.
Gök et al. (2015) conducted a case-control in Systemic hypertension (n=232). Systemic hypertension vs. Healthy controls was evaluated on Subfoveal choroidal thickness (SFCT) (p=≤0.611). Systemic hypertension did not significantly affect subfoveal choroidal thickness compared to healthy controls (P≤0.611).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: